LeMaitre Vascular, Inc. (LMAT) To Go Ex-Dividend on August 20th

LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced a quarterly dividend on Tuesday, July 28th. Shareholders of record on Thursday, August 20th will be paid a dividend of 0.25 per share by the medical instruments supplier on Thursday, September 3rd. This represents a c) annualized dividend and a yield of 1.2%. The ex-dividend date is Thursday, August 20th.

LeMaitre Vascular has raised its dividend payment by an average of 0.2%annually over the last three years and has raised its dividend annually for the last 14 consecutive years. LeMaitre Vascular has a dividend payout ratio of 42.0% meaning its dividend is sufficiently covered by earnings. Analysts expect LeMaitre Vascular to earn $3.17 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 31.5%.

LeMaitre Vascular Trading Up 0.2%

NASDAQ:LMAT opened at $82.51 on Tuesday. The firm has a fifty day simple moving average of $95.25 and a 200-day simple moving average of $99.75. LeMaitre Vascular has a 12 month low of $78.65 and a 12 month high of $118.01. The company has a current ratio of 16.31, a quick ratio of 13.96 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $1.89 billion, a P/E ratio of 28.95, a PEG ratio of 2.38 and a beta of 0.53.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.07). The business had revenue of $70.38 million during the quarter, compared to analyst estimates of $71.47 million. LeMaitre Vascular had a return on equity of 15.63% and a net margin of 25.02%.The firm’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.60 EPS. On average, equities research analysts anticipate that LeMaitre Vascular will post 2.89 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of LMAT. Sound Income Strategies LLC boosted its position in shares of LeMaitre Vascular by 425.6% during the first quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier’s stock worth $25,000 after buying an additional 183 shares during the period. Catalyst Capital Advisors LLC purchased a new position in shares of LeMaitre Vascular in the 1st quarter valued at about $32,000. Geneos Wealth Management Inc. grew its holdings in LeMaitre Vascular by 250.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 557 shares of the medical instruments supplier’s stock worth $47,000 after acquiring an additional 398 shares in the last quarter. EverSource Wealth Advisors LLC acquired a new position in shares of LeMaitre Vascular during the second quarter worth $47,000. Finally, Quarry LP boosted its position in shares of LeMaitre Vascular by 267.2% during the 3rd quarter. Quarry LP now owns 727 shares of the medical instruments supplier’s stock worth $64,000 after acquiring an additional 529 shares in the last quarter. Hedge funds and other institutional investors own 84.64% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.